M&A: Page 2
-
Edwards continues M&A spree with Genesis’ TAVR tech
Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.
By Susan Kelly • Aug. 19, 2024 -
Courtesy of Boston Scientific
Boston Scientific resubmits Silk Road merger filing, giving FTC more review time
A Boston Scientific spokesperson said the company still expects to close its $1.26 billion purchase of Silk Road Medical in the second half of the year.
By Ricky Zipp • Aug. 16, 2024 -
Permission granted by Neuronetics
Neuronetics inks Greenbrook merger to acquire treatment centers
William Blair analysts said the deal changes Neuronetics’ profile “from device-centric to a device-service business operating brick-and-mortar facilities.”
By Nick Paul Taylor • Aug. 15, 2024 -
Tim Boyle via Getty Images
Baxter agrees to sell kidney care unit to Carlyle for $3.8B
Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said.
By Susan Kelly • Aug. 13, 2024 -
Retrieved from Care.ai on August 12, 2024
Stryker to buy smart hospital technology firm Care.ai
The deal comes shortly after Stryker CEO Kevin Lobo told investors to expect a “very active deal pipeline” for the second half of 2024.
By Elise Reuter • Aug. 12, 2024 -
Courtesy of 23andMe
23andMe board rejects CEO Wojcicki’s take-private proposal
A special committee of the board said the proposal offers no premium to 23andMe’s stock price, and with a lack of committed financing, is “insufficient.”
By Elise Reuter • Aug. 2, 2024 -
Brad Barket via Getty Images
23andMe CEO proposes to take company private
Anne Wojcicki, who co-founded 23andMe, would pay 40 cents per share to buy the DNA testing company, which has been trading under $1 for nearly a year.
By Elise Reuter • Aug. 1, 2024 -
ridvan_celik via Getty Images
Asensus updates Karl Storz merger filing after investors make demands
Asensus denied that there were deficiencies in the original disclosure of the proposed takeover by Karl Storz but voluntarily expanded on details to avoid lawsuits or delays.
By Nick Paul Taylor • July 30, 2024 -
rustycanuck via Getty Images
Owens & Minor inks $1.36B takeover of Rotech
Rotech will help Owens & Minor get closer to its 2028 sales goal with home medical equipment, including sleep and oxygen devices, hospital beds and wheelchairs.
By Nick Paul Taylor • July 25, 2024 -
Mario Tama via Getty Images
Top 5 medtech deals in the first half of 2024
The first six months of the year brought a series of multibillion-dollar deals, led by Johnson & Johnson’s $13.1 billion takeover of Shockwave Medical.
By Nick Paul Taylor • July 24, 2024 -
Courtesy of Cook Medical
Cook Medical to sell reproductive health business to private equity firm
Astorg intends to combine the Cook assets with Hamilton Thorne, another reproductive health business it plans to buy.
By Nick Paul Taylor • July 23, 2024 -
Permission granted by Nasdaq
Diabetes device firm Embecta considers sale: Financial Times
Two years after Embecta spun out of BD, the firm is now exploring a potential sale, the Financial Times reported.
By Elise Reuter • July 22, 2024 -
Peter Macdiarmid via Getty Images
Dental implant maker Osstem in talks to acquire Zimvie: report
Bloomberg first reported M&A rumors in June when Zimvie was approached about a takeover.
By Elise Reuter • July 19, 2024 -
Stringer via Getty Images
GE Healthcare to buy AI software from Intelligent Ultrasound for $51M
After purchasing Caption Health last year, GE Healthcare plans to add another artificial intelligence acquisition to the company.
By Nick Paul Taylor • July 19, 2024 -
Courtesy of Edwards Lifesciences
Edwards to acquire Innovalve, stake in Affluent Medical
The heart valve specialist said in a federal filing that it expects to pay $300 million in cash for Innovalve Bio Medical when the deal closes.
By Susan Kelly • July 15, 2024 -
Courtesy of Illumina
Illumina buys Fluent Biosciences, adding single-cell analysis tech
Fluent’s kits compete with products from companies including 10x Genomics, an Illumina partner.
By Nick Paul Taylor • July 10, 2024 -
Courtesy of Masimo
Masimo offered up to $950M for consumer business
Final terms of the deal are still being discussed, and Masimo said it plans to negotiate a higher price.
By Nick Paul Taylor • July 9, 2024 -
saengsuriya13 via Getty Images
Baxter considers sale of kidney care unit to PE firm: WSJ
Carlyle Group could reportedly pay more than $4 billion for Baxter’s Vantive business.
By Elise Reuter • July 8, 2024 -
Courtesy of Quest Diagnostics
Quest to buy Lifelabs for $985M
Buying the Canadian laboratory company opens a new front in Quest’s rivalry with Labcorp and marks its third takeover in as many months.
By Nick Paul Taylor • July 8, 2024 -
Zorica Nastasic via Getty Images
Alcon buys Belkin Vision for $81M upfront
Alcon will gain access to a laser treatment for glaucoma that it plans to sell in the U.S. by the end of the year.
By Nick Paul Taylor • July 3, 2024 -
Jajah-sireenut via Getty Images
Merit Medical pays Endogastric $105M for acid reflux treatment
Merit expects the device to add around $30 million in annual sales.
By Nick Paul Taylor • July 2, 2024 -
Mario Tama/Getty via Getty Images
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
By Nick Paul Taylor • July 1, 2024 -
Peter Macdiarmid via Getty Images
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
By Nick Paul Taylor • June 26, 2024 -
Courtesy of Boston Scientific
Boston Scientific buys Silk Road Medical for $1.26B
Silk Road developed a minimally invasive procedure to prevent stroke in patients with carotid artery disease.
By Susan Kelly • June 18, 2024 -
Courtesy of Grail
Illumina board approves Grail spinoff
Leerink Partners analyst Puneet Souda said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for years to come.”
By Susan Kelly • June 4, 2024
Previous
